Two Sigma Securities’s Lexaria Bioscience LEXX Stock Holding History

Two Sigma Securities’s Portfolio LEXX Stock Details LEXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,545	Closed	-$10.5K	–	3350
2023 Q3	$10.5K	Buy	+10,545	New	+$9.63K	﹤0.01%	2690

Other funds holding LEXX

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Two Sigma Securities's LEXX Position: Q4 2023 in Review

Two Sigma Securities sold out of Lexaria Bioscience (LEXX) in Q4 2023, closing a stake of 10,545 shares — an estimated $10.5K sold.

Two Sigma Securities first reported a position in LEXX in Q3 2023 and held it in 1 quarter. The position peaked at $10.5K in Q3 2023. 20 funds tracked by Wall St. Rank hold LEXX as of Q4 2023.

Two Sigma Securities reported no remaining Lexaria Bioscience position as of Q4 2023 after selling out during the quarter.
Two Sigma Securities sold 10,545 Lexaria Bioscience shares in Q4 2023, an estimated $10.5K.
Two Sigma Securities first reported a position in Lexaria Bioscience in Q3 2023 and held it in 1 quarter.
Two Sigma Securities's Lexaria Bioscience position peaked at $10.5K in Q3 2023.
20 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q4 2023.

Based on Two Sigma Securities's 13F filing for Q4 2023, filed 14 Feb 2024.